Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8988)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2015 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Simon TG, Butt AA. Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes. World J Gastroenterol 2015; 21(27): 8293-8303 [PMID: 26217081 DOI: 10.3748/wjg.v21.i27.8293] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i27/8293.htm |
| Number | Citing Articles |
| 1 |
Joana Rita Carvalho, José Velosa, Fátima Serejo. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication – comparison of the new direct-acting antiviral agents with the old regimens. Scandinavian Journal of Gastroenterology 2018; 53(7): 857 doi: 10.1080/00365521.2018.1473486
|
| 2 |
Ruirui Feng, Xiaozhong Guo, Yun Kou, Xiangbo Xu, Cen Hong, Wenwen Zhang, Yang An, Cyriac Abby Philips, Andrea Mancuso, Xingshun Qi. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis. Postgraduate Medicine 2021; 133(6): 626 doi: 10.1080/00325481.2021.1930560
|
| 3 |
Stanford Schor, Shirit Einav. Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs. ACS Infectious Diseases 2018; 4(2): 88 doi: 10.1021/acsinfecdis.7b00268
|
| 4 |
Nora T. Oliver, Christine M. Hartman, Jennifer R. Kramer, Elizabeth Y. Chiao. Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals. AIDS 2016; 30(16): 2469 doi: 10.1097/QAD.0000000000001219
|
| 5 |
Beatrice Conti, Cristiana Porcu, Carmela Viscomi, Antonella Minutolo, Susan Costantini, Marco Corazzari, Gino Iannucci, Barbara Barbaro, Clara Balsano. Small heterodimer partner 1 directly interacts with NS5A viral protein and has a key role in HCV related liver cell transformation. Oncotarget 2016; 7(51): 84575 doi: 10.18632/oncotarget.12144
|
| 6 |
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres. Hepatitis C eradication with sofosbuvir leads to significant metabolic changes. World Journal of Hepatology 2016; 8(35): 1557-1563 doi: 10.4254/wjh.v8.i35.1557
|
| 7 |
Ayush Jain, Bhupinder Singh Kalra, Siddharth Srivastava, Shalini Chawla. Effect of sofosbuvir and daclatasvir on lipid profile, glycemic control and quality of life index in chronic hepatitis C, genotype 3 patients. Indian Journal of Gastroenterology 2019; 38(1): 39 doi: 10.1007/s12664-019-00935-w
|
| 8 |
Payal Kohli, Peter Ganz, Yifei Ma, Rebecca Scherzer, Sophia Hur, Bernard Weigel, Carl Grunfeld, Steven Deeks, Scott Wasserman, Rob Scott, Priscilla Y. Hsue. HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent “PCSK9–Lipid Paradox”. Journal of the American Heart Association 2016; 5(5) doi: 10.1161/JAHA.115.002683
|
| 9 |
Pakkapon Rattanachaisit, Paweena Susantitaphong, Kessarin Thanapirom, Roongruedee Chaiteerakij, Piyawat Komolmit, Pisit Tangkijvanich, Sombat Treeprasertsuk. Statin use and histopathological change in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Asian Biomedicine 2018; 12(1): 3 doi: 10.1515/abm-2018-0026
|
| 10 |
Etienne Ho Kit Mok, Terence Kin Wah Lee. The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets. Cancers 2020; 12(6): 1410 doi: 10.3390/cancers12061410
|
| 11 |
Marwah Karim, Chieh-Wen Lo, Shirit Einav. Preparing for the next viral threat with broad-spectrum antivirals. Journal of Clinical Investigation 2023; 133(11) doi: 10.1172/JCI170236
|
| 12 |
Knut Stokkeland, Christine Takami Lageborn, Anders Ekbom, Jonas Höijer, Matteo Bottai, Per Stål, Karin Söderberg‐Löfdal. Statins and Angiotensin‐Converting Enzyme Inhibitors are Associated with Reduced Mortality and Morbidity in Chronic Liver Disease. Basic & Clinical Pharmacology & Toxicology 2018; 122(1): 104 doi: 10.1111/bcpt.12844
|
| 13 |
Che-Pin Chang, Yuan-Chih Su, Mei-Chen Lin, Sheng-Teng Huang. Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort Study. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/5319456
|
| 14 |
|
| 15 |
Takashi Himoto, Koji Fujita, Teppei Sakamoto, Takako Nomura, Asahiro Morishita, Hirohito Yoneyama, Reiji Haba, Tsutomu Masaki. Clinical efficacy of free androgen index, a surrogate hallmark of circulating free testosterone level, in male patients with HCV-related chronic liver disease. Journal of Clinical Biochemistry and Nutrition 2018; 63(3): 238 doi: 10.3164/jcbn.18-30
|
| 16 |
Emilie Crouchet, Florian Wrensch, Catherine Schuster, Mirjam B. Zeisel, Thomas F. Baumert. Host-targeting therapies for hepatitis C virus infection: current developments and future applications. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818759483
|
| 17 |
Pei-Shan Tsai, Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao. The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease. European Journal of Gastroenterology & Hepatology 2023; 35(11): 1278 doi: 10.1097/MEG.0000000000002558
|
| 18 |
Matthew M. Fanous, Eugenia Gianos, Laurence S. Sperling, Guy L. Mintz, David T. Majure, Benjamin J. Hirsh. Early use of PCSK9 inhibitor therapy after heart transplantation from a hepatitis C virus positive donor. Journal of Clinical Lipidology 2021; 15(4): 579 doi: 10.1016/j.jacl.2021.05.003
|